- $31.44bn
- $31.34bn
- $2.82bn
Annual balance sheet for Teradyne, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,436 | 1,366 | 894 | 820 | 600 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 498 | 551 | 491 | 422 | 471 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,415 | 2,576 | 2,258 | 2,162 | 1,816 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 449 | 456 | 492 | 519 | 578 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,652 | 3,809 | 3,501 | 3,487 | 3,709 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 701 | 805 | 746 | 660 | 625 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,442 | 1,245 | 1,050 | 961 | 889 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,211 | 2,564 | 2,451 | 2,526 | 2,819 |
| Total Liabilities & Shareholders' Equity | 3,652 | 3,809 | 3,501 | 3,487 | 3,709 |
| Total Common Shares Outstanding |